Trial
NCT02707900
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
HIV-1 Infection
Intervention
Vorinostat
Why stopped
Manufacturing of the AGS-004 HIV vaccine by Argos could no longer be provided.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-07